Search Results 1091-1100 of 18137 for Topical

1. Clinical trials - Oncology (Medical)

   Dietary and Topical Magnesium Replacement or Supplementation in Patients with Lymphoma. Rochester, Minn. The purpose of this research study is to find out if ...

2. A Study to Evaluate the Effectiveness of Antihistamines in the Treatment of Eosinophilic Esophagitis - Mayo Clinic

   Patients who have used topical or systemic corticosteroid therapy for any reason in the previous 6 weeks. Patients who have been treated with acid ...

3. Publications - Nahid Y. Vidal, M.D. - Mayo Clinic

   Dramatic saxophone penis as a result of topical imiquimod use. JAMA Dermatol. 2014 Dec; 150 (12):1370-1. View PubMed. PST-20492609. Home; Publications. Fuel ...

4. A Study of the Safety and Effectiveness of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution for Non-Infectious Anterior Uveitis - Mayo Clinic

   Has used topical corticosteroid treatment in the study eye within the 48 hours prior to the visit 1 assessments; Has used oral corticosteroid within the past ...

5. A Prospective Study to Establish a New Onset Hyperglycemia and Diabetes (NOD) Cohort - Mayo Clinic

   *Allowed: Nasal, topical steroids, oral budesonide, ophthalmic. Subject must not have had a recent (within 1 week of the elevated index lab) intra-articular ...

6. Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) - Mayo Clinic

   Topical (rectal) treatment with 5-ASAs or corticosteroids;; Probiotics (example, Saccharomyces boulardii);; Antidiarrheals (example, loperamide, diphenoxylate ...

7. AMG 181 Phase 2 Study in Subjects with Moderate to Severe Ulcerative Colitis - Mayo Clinic

   Use of topical (rectal) aminosalicylic acid (eg, mesalamine) or topical (rectal) steroids within 2 weeks prior to baseline; Use of intravenous or ...

8. Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides - Mayo Clinic

   Topical steroid creams for symptomatic relief for patients in Cohort C (TMF) are exceptions to this rule. Also, the use of physiologic doses of ...

9. A Study to Evaluate AFPᶜ³³²T in Advanced HCC - Mayo Clinic

   NOTE: Use of inhaled or topical steroids is not exclusionary. Sorafenib/Regorafenib/Lenvatinib within 1 week;; Cabozantinib within 2 weeks;; Duration of ...

10. Publications - Nessa Aghazadeh Mohandesi, M.D. - Mayo Clinic

    2023 Jul; 62(7):938-945. Epub 2023 Mar 08. View PubMed; Sadeghi S, Mohandesi NA. Efficacy and safety of topical JAK inhibitors in the treatment of atopic ...